Your browser doesn't support javascript.
loading
Fatigue in de novo Parkinson's Disease: Expanding the Neuropsychiatric Triad?
Béreau, Matthieu; Castrioto, Anna; Lhommée, Eugénie; Maillet, Audrey; Gérazime, Aurélie; Bichon, Amélie; Pélissier, Pierre; Schmitt, Emmanuelle; Klinger, Hélène; Longato, Nadine; Fraix, Valérie; Benatru, Isabelle; Durif, Franck; Azulay, Jean-Philippe; Moro, Elena; Broussolle, Emmanuel; Tranchant, Christine; Anheim, Mathieu; Thobois, Stéphane; Krack, Paul.
Afiliação
  • Béreau M; Department of Neurology, University Hospital of Besançon, Besançon, France.
  • Castrioto A; Laboratoire de Recherches Intégratives en Neurosciences et Psychologie Cognitive - UR LINC, Université Bourgogne Franche-Comté, Besançon, France.
  • Lhommée E; NS-PARK/FCRIN Network, France.
  • Maillet A; University Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, Movement Disorders Unit, Grenoble Institut Neurosciences, Grenoble, France.
  • Gérazime A; University Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, Movement Disorders Unit, Grenoble Institut Neurosciences, Grenoble, France.
  • Bichon A; Movement Disorders Unit, Neurology Department, Hospices Civils de Lyon, University Lyon, Lyon, France.
  • Pélissier P; Faculté de Médecine Lyon Sud, Université Claude Bernard Lyon 1, Lyon, France.
  • Schmitt E; CNRS, Institut des Sciences Cognitives Marc Jeannerod, UMR 5229, Bron, France.
  • Klinger H; Unité de Méthodologie, CIC INSERM 1431, CHRU de Besançon, Besançon, France.
  • Longato N; University Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, Movement Disorders Unit, Grenoble Institut Neurosciences, Grenoble, France.
  • Fraix V; University Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, Movement Disorders Unit, Grenoble Institut Neurosciences, Grenoble, France.
  • Benatru I; University Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, Movement Disorders Unit, Grenoble Institut Neurosciences, Grenoble, France.
  • Durif F; Movement Disorders Unit, Neurology Department, Hospices Civils de Lyon, University Lyon, Lyon, France.
  • Azulay JP; Faculté de Médecine Lyon Sud, Université Claude Bernard Lyon 1, Lyon, France.
  • Moro E; CNRS, Institut des Sciences Cognitives Marc Jeannerod, UMR 5229, Bron, France.
  • Broussolle E; Service de Neurologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
  • Tranchant C; University Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, Movement Disorders Unit, Grenoble Institut Neurosciences, Grenoble, France.
  • Anheim M; Department of Neurology, University Hospital of Poitiers, Poitiers, France.
  • Thobois S; INSERM, CHU de Poitiers, University of Poitiers, Centre d'Investigation Clinique CIC1402, Poitiers, France.
  • Krack P; Neurology Department, Université Clermont Auvergne, EA7280 NPsy-Sydo, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.
J Parkinsons Dis ; 12(4): 1329-1337, 2022.
Article em En | MEDLINE | ID: mdl-35253781
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Apatia Tipo de estudo: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Apatia Tipo de estudo: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article